NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE
1 –DESCRIPTION OF OPERATIONS AND BASIS OF PRESENTATION
Sharing
Services Global Corporation (“Sharing Services” or “the Company”) is a holding company, with Elepreneurs
Holdings, LLC and Elevacity Holdings, LLC as its main operating subsidiaries. The
Company is an emerging growth company that primarily markets and distributes health and wellness products under the Elevate brand
through an independent sales force of distributors, or “Elepreneurs,” using a marketing strategy which is a form of
direct selling. The Company’s Elevate health and wellness product line was launched in December 2017 and consists of Nutraceutical
products that the Company refers to as “D.O.S.E.” (which stands for: Dopamine, Oxytocin, Serotonin and Endorphins).
The
condensed consolidated interim financial statements included herein have been prepared in accordance with accounting principles
generally accepted in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange
Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared
in accordance with GAAP have been condensed or omitted as permitted pursuant to the rules and regulations of the SEC, although
we believe that the disclosures made are adequate to make the information not misleading. These condensed consolidated financial
statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s
Annual Report on Form 10-K for the fiscal year ended April 30, 2019.
Recent
Corporate Name Change
In
January 2019, Sharing Services, Inc. changed its corporate name to Sharing Services Global Corporation to better reflect the Company’s
strategic intent to grow its business globally. The corporate name change was approved by the Company’s stockholders and
by its Board of Directors. In connection with the name change, the Company adopted the over-the-counter trading symbol “SHRG.”
Going
Concern
The
accompanying consolidated financial statements have been prepared on a going concern basis, which assumes the Company will be
able to realize its assets and settle its liabilities in the ordinary course of its business for the foreseeable future. The Company
is an emerging growth company and, prior to its fiscal quarter ended January 31, 2018, the Company had virtually no sales. However,
the Company’s net sales and/or gross margin generally have increased each quarter since the December 2017 launch of its
Elevate health and wellness product line. For the full fiscal year ended April 30, 2019, cash provided by operations was $6.0
million, on sales of $85.9 million while, for the nine months ended January 31, 2020, cash provided by operations was $7.7 million,
on sales of $106.0 million. As of January 31, 2020, cash and cash equivalents were $8.2 million.
The
Company believes it will be able to fund its working capital needs for the next 12 months with existing cash and cash equivalents,
cash to be provided by operations, secured and unsecured debt, including through the issuance of convertible notes and short-term
borrowings under financing arrangements, and capital transactions from time to time. Accordingly, the Company believes there is
no longer reasonable doubt as to the Company’s ability to continue as a going concern in the foreseeable future.
NOTE
2 –SIGNIFICANT ACCOUNTING POLICIES
We
adhere to the same accounting policies in the preparation of our condensed consolidated interim financial statements as we do
in the preparation of our full year consolidated financial statements. As permitted under GAAP, interim accounting for certain
expenses is based on full-year assumptions.
Reclassifications
Certain
reclassifications have been made to the prior period data to conform with the current period’s presentation.
Comprehensive
Income
For
the fiscal periods included in this Quarterly Report, the only component of the Company’s comprehensive income (loss) is
the Company’s net earnings (loss). Accordingly, the Company does not present a consolidated statement of comprehensive income.
Use
of Estimates and Assumptions
The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent assets and liabilities, if
any. Examples of estimates and assumptions include: the recoverability of accounts receivable, the valuation of inventory, the
useful lives of fixed assets, the assessment of long-lived assets for impairment, the measurement and recognition of right-of-use
assets and related lease liabilities, the valuation and recognition of derivative liabilities, the measurement and recognition
of stock-based compensation expense, the measurement and recognition of revenues, the nature and timing of satisfaction of performance
obligations resulting from contracts with customers, the measurement and recognition of uncertain tax positions, and the valuation
of loss contingencies, if any. Actual results may differ from these estimates in amounts that may be material to our consolidated
financial statements. We believe that the estimates and assumptions used in the preparation of our consolidated financial statements
are reasonable.
Revenue
Recognition
The
Company derives revenue only from the sale of its products and services and recognizes revenue net of amounts due to taxing authorities
(such as local and state sales tax). Our customers place sales orders online and through our “back-office” operations,
which creates a contract and establishes the transaction price. The Company recognizes revenue when (or as) it transfers control
of the promised goods and services to the customer. With respect to products sold, our performance obligation is satisfied upon
receipt of the products by the customer. With respect to subscription-based services, including Elepreneur membership fees, our
performance obligation is satisfied over time (up to one year). The timing of our revenue recognition may differ from the time
when we invoice and/or collect payment. The Company has elected to treat shipping and handling costs as an activity to fulfill
its performance obligations, rather than a separate performance obligation.
Deferred
revenue associated with product invoiced but not received by customers at the balance sheet date was $1.2 million and $2.5 million
as of January 31, 2020 and April 30, 2019, respectively. In addition, as of January 31, 2020 and April 30, 2019, deferred revenue
associated with our performance obligations for services offered on a subscription basis was $460,896 and $515,087, and deferred
revenue associated with our performance obligations for customers’ right of return was $215,979 and $194,042, respectively.
Deferred revenue is expected to be recognized over one year and is reported in accrued and other current liabilities on our consolidated
balance sheets.
No
individual customer, or related group of customers, represents 10% or more of our consolidated net sales. Over 94% of our consolidated
net sales are from sales to our customers and/or independent distributors located in the United States. During the nine months
ended January 31, 2020, approximately 50% of our consolidated net sales were to recurring customers, approximately 25% were to
new customers, and approximately 25% were to our independent distributors.
During
the nine months ended January 31, 2020, approximately 98% of our consolidated net sales are from our Elevate
product line (including approximately 25% from the sales of coffee and coffee-related products and approximately 52% from
the sale of all other D.O.S.E. Nutraceutical products). During the nine months ended January 31, 2020 and 2019, product purchases
from one supplier accounted for approximately 98% and 95%, respectively, of our total product purchases.
Sales
Commission
The
Company recognizes sales commission expense, when incurred, in accordance with GAAP. During the three months ended January 31,
2020 and 2019, sales commission expense was $14.0 million and $12.7 million, respectively. During the nine months ended January
31, 2020 and 2019, sales commission expense was $47.6 million and $26.3 million, respectively. Sales commission expense is included
in selling and marketing expenses in our consolidated statements of operations.
As
of January 31, 2020 and April 30, 2019, accrued sales commission payable was $8,491,081 and $7,402,659, respectively; including
$1,290,599 and $1,365,705, respectively, payable with stock warrants.
Accounting
Changes
In
February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases, which requires lessees
to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified
as operating leases under the prior guidance. As permitted, the Company adopted the new guidance, codified as Accounting Standards
Codification (“ASC”) Topic 842, Leases, effective May 1, 2019 using the optional cumulative-effect transition
method, and adoption resulted in an initial lease liability in the aggregate amount of approximately $1.4 million and right-of-use
assets in the same aggregate amount. The Company’s right-of-use assets relate to leases involving office space, automobiles
and office equipment, and are amortized over periods ranging from one to three years. The adoption of ASC Topic 842 did not otherwise
have a material impact on the Company’s consolidated financial statements.
Recently
Issued Accounting Standards
In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) which modifies the disclosure requirements
on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (“ASC 820”). For public
companies, ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level
2 of the fair value hierarchy contained in ASC Topic 820, (b) the policy for timing of transfers between levels, and (c) the valuation
processes used for level 3 fair value measurements. For public companies, ASU 2018-13 also adds, among other things, a requirement
to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements. The Company
adopted ASU 2018-13 effective February 1, 2020 and such adoption did not have a material effect on its consolidated financial
statements.
NOTE
3 – FAIR VALUE MEASURENTS OF FINANCIAL INSTRUMENTS
Our
financial instruments consist of cash equivalents, if any, accounts receivable, notes receivable, investments in unconsolidated
entities, accounts payable, notes payable and derivative liabilities. The carrying amounts of cash equivalents, if any, trade
accounts receivable, notes receivable, and accounts payable approximate their respective fair values due to the short-term nature
of these financial instruments.
Consistent
with the valuation hierarchy contained in ASC Topic 820, we categorized certain of our financial assets and liabilities as follows:
|
|
January 31, 2020
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, related party
|
|
$
|
3,456,751
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,456,751
|
|
Investments in unconsolidated entities
|
|
|
20,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
20,000
|
|
Total assets
|
|
$
|
3,476,751
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,476,751
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable
|
|
$
|
110,736
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
110,736
|
|
Notes payable
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total liabilities
|
|
$
|
110,736
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
110,736
|
|
|
|
April 30, 2019
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, related party
|
|
$
|
3,446,114
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,446,114
|
|
Investments in unconsolidated entities
|
|
|
207,500
|
|
|
|
-
|
|
|
|
-
|
|
|
|
207,500
|
|
Total assets
|
|
$
|
3,653,614
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,653,614
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable
|
|
$
|
870,567
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
870,567
|
|
Notes payable
|
|
|
2,123,208
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,123,208
|
|
Total liabilities
|
|
$
|
2,993,775
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
2,993,775
|
|
NOTE
4 – EARNINGS (LOSS) PER SHARE
We
calculate basic earnings (loss) per share by dividing net earnings (loss) available to common shareholders by the weighted average
number of common shares outstanding during the reporting period. Diluted earnings per share is calculated similarly but reflects
the potential impact of outstanding convertible preferred stock, stock warrants and other commitments to issue common stock, including
shares issuable upon the conversion of convertible notes, except where the impact would be anti-dilutive.
The
following table sets forth the computations of basic and diluted earnings (loss) per share:
|
|
Three Months Ended January 31,
|
|
|
Nine Months Ended January 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Net earnings (loss), as reported
|
|
$
|
2,379,982
|
|
|
$
|
(2,617,723
|
)
|
|
$
|
294,255
|
|
|
$
|
27,442,271
|
|
After tax interest adjustment
|
|
|
1,185
|
|
|
|
-
|
|
|
|
35,716
|
|
|
|
110,639
|
|
Net earnings (loss), if-converted basis
|
|
$
|
2,381,167
|
|
|
$
|
(2,617,723
|
)
|
|
$
|
329,971
|
|
|
$
|
27,552,910
|
|
Weighted average basic shares
|
|
|
133,272,386
|
|
|
|
77,603,622
|
|
|
|
125,535,104
|
|
|
|
70,437,299
|
|
Dilutive securities and instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible preferred stock
|
|
|
45,957,554
|
|
|
|
-
|
|
|
|
46,176,467
|
|
|
|
101,879,204
|
|
Convertible notes
|
|
|
10,406,100
|
|
|
|
-
|
|
|
|
54,606,397
|
|
|
|
54,825,175
|
|
Stock options and warrants
|
|
|
21,760,510
|
|
|
|
-
|
|
|
|
20,253,606
|
|
|
|
5,649,529
|
|
Weighted average diluted shares
|
|
|
211,396,550
|
|
|
|
77,603,622
|
|
|
|
246,571,574
|
|
|
|
232,791,207
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.02
|
|
|
$
|
(0.03
|
)
|
|
$
|
0.00
|
|
|
$
|
0.39
|
|
Diluted
|
|
$
|
0.01
|
|
|
$
|
(0.03
|
)
|
|
$
|
0.00
|
|
|
$
|
0.12
|
|
The
following potentially dilutive securities and instruments were outstanding during the three months ended January 31, 2019 but
excluded from the table above because their impact would be anti-dilutive:
|
|
|
|
Convertible preferred stock
|
|
|
56,998,750
|
|
Convertible notes
|
|
|
89,186,267
|
|
Stock options and warrants
|
|
|
2,513,333
|
|
Total incremental shares
|
|
|
148,698,350
|
|
NOTE
5 – NOTES RECEIVABLE
In
March and April 2018, the Company entered into certain investment agreements with a third party pursuant to which the Company
loaned an aggregate of $275,000 to the third party. The related promissory notes accrued interest at the rate of 12% per annum.
In June 2019, the Company and the third party entered into a loan exchange agreement pursuant to which the Company received a
promissory note for $309,309 in settlement of all amounts owed to the Company under the March and April 2018 loans, including
loan principal of $275,000 and accrued interest of $34,309. Loans under the June 2019 promissory note bear interest at the rate
of 8% per annum. In October 2019, after exhausting all efforts to collect the amounts due pursuant to the June 2019 promissory
note, the Company recognized an impairment loss of $317,105 in connection therewith. For the nine months ended January 31, 2020
and 2019, interest income earned in connection with our promissory notes, excluding promissory notes from a related party, was
$15,620 and $24,953, respectively.
In
the fiscal year 2019, the Company received a promissory note for $106,404 from a prior merchant processor in connection with amounts
owed to the Company. The Company and the issuer have been in negotiations aimed at settling this balance. On March 2, 2020, the
Company and the issuer of the note reached an agreement pursuant to which the Company expect to collect $60,000 in full payment
of the balance owed to it. In January 2020, the Company recognized an impairment loss of $46,404 in connection therewith.
NOTE
6 – OTHER CURRENT ASSETS
Other current assets consist of the following:
|
|
January 31, 2020
|
|
|
April 30, 2019
|
|
Prepaid expenses
|
|
$
|
219,094
|
|
|
$
|
270,625
|
|
Right to recover asset
|
|
|
63,349
|
|
|
|
65,257
|
|
Interest receivable, including $206,066 due from related parties at January 31
|
|
|
206,066
|
|
|
|
36,678
|
|
Other
|
|
|
1,207
|
|
|
|
750
|
|
|
|
$
|
489,716
|
|
|
$
|
373,310
|
|
NOTE
7 – PROPERTY AND EQUIPMENT
Property
and equipment consist of the following:
|
|
January 31, 2020
|
|
|
April 30, 2019
|
|
Furniture and fixtures
|
|
$
|
224,239
|
|
|
$
|
193,737
|
|
Computer equipment and software
|
|
|
148,537
|
|
|
|
91,223
|
|
Leasehold improvements
|
|
|
103,340
|
|
|
|
82,981
|
|
Office equipment
|
|
|
31,652
|
|
|
|
30,601
|
|
Total property and equipment
|
|
|
507,768
|
|
|
|
398,542
|
|
Accumulated depreciation and amortization
|
|
|
(178,523
|
)
|
|
|
(91,018
|
)
|
Property and equipment, net
|
|
$
|
329,245
|
|
|
$
|
307,524
|
|
Depreciation
and amortization expense was $40,264 and $22,850 for the three months ended January 31, 2020 and 2019 and, for the nine months
ended January 31, 2020 and 2019, $87,506 and $54,760, respectively.
NOTE
8 – INVESTMENTS IN UNCONSOLIDATED ENTITIES
In
the fiscal year ended April 30, 2019, the Company recognized an impairment loss in the aggregate amount of $4.4 million in connection
with its investments in unconsolidated entities as a result of a less than temporary decline in the value of the Company’s
investment. In addition, in the nine months ended January 31, 2020, the Company recognized an impairment loss in the amount of
$187,500 in connection with its investments in an unconsolidated entity as a result of a less than temporary decline in the value
of the Company’s investment. The information contained in Note 8 of the Notes to Consolidated Financial Statements included
in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2019 is incorporated herein by reference.
See Note 16 below for contingencies and other matters associated with the Company’s investments in unconsolidated entities.
NOTE
9 - NOTES PAYABLE
On
December 11, 2018, the Company entered into a Loan Agreement and Promissory Note (the “loan agreement”) with Global
Payroll Gateway pursuant to which the Company borrowed the principal amount of $1,000,000. Borrowings under the loan agreement
were payable in 52 weekly installments. Consistent with the terms of the loan agreement, on December 11, 2019, the Company paid
in full all principal and interest outstanding thereunder.
In
the nine months ended January 31, 2020, the Company paid in full all borrowings under financing arrangements with third-party
lenders, including borrowings under the loan agreement discussed above. At April 30, 2019, notes payable, consisting of short-term
borrowings under financing arrangements, in the aggregate, were $2,123,208, net of unamortized debt discount of $379,777. Borrowings
under the Company’s financing arrangements were secured by a lien on the Company’s accounts receivable, inventory
and property and equipment.
NOTE
10 - ACCRUED AND OTHER CURRENT LIABILITIES
Accrued
and other current liabilities consist of the following:
|
|
January 31, 2020
|
|
|
April 30, 2019
|
|
State and local taxes payable
|
|
$
|
2,003,225
|
|
|
$
|
1,913,638
|
|
Payroll and payroll related
|
|
|
1,123,128
|
|
|
|
37,807
|
|
Lease liability, current portion
|
|
|
496,241
|
|
|
|
-
|
|
Accrued shipping and freight
|
|
|
165,716
|
|
|
|
226,695
|
|
Accrued interest payable
|
|
|
13,940
|
|
|
|
139,746
|
|
Other operational accruals
|
|
|
411,540
|
|
|
|
290,887
|
|
|
|
$
|
4,213,790
|
|
|
$
|
2,608,773
|
|
Lease
liability, current portion, represent obligations under leases that are payable within one year for office space, automobiles
and office equipment. See Note 2 of the Condensed Notes to the Consolidated Financial Statements above for information about the
Company’s adoption of ASC Topic 842, Leases.
NOTE
11 - CONVERTIBLE NOTES PAYABLE
Convertible
notes payable consists of the following:
|
|
|
|
|
Conversion Price
|
|
|
|
|
Issuance Date
|
|
Maturity Date
|
|
|
(per share)
|
|
|
January 31, 2020
|
|
|
April 30, 2019
|
|
October 2017
|
|
|
October 2022
|
|
|
$
|
0.15
|
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
November 2017
|
|
|
On Demand
|
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
5,000
|
|
January 2018
|
|
|
On Demand
|
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
250,000
|
|
February 2018
|
|
|
On Demand
|
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
250,000
|
|
March 2018
|
|
|
On Demand
|
|
|
$
|
0.01
|
|
|
|
-
|
|
|
|
250,000
|
|
April 2018
|
|
|
April 2021
|
|
|
$
|
0.01
|
|
|
|
100,000
|
|
|
|
100,000
|
|
Total convertible notes payable
|
|
|
|
|
|
|
|
150,000
|
|
|
|
905,000
|
|
Less: unamortized debt discount and deferred financing fees
|
|
|
|
|
|
|
|
(39,264
|
)
|
|
|
(34,433
|
)
|
|
|
|
|
|
|
|
|
|
|
|
110,736
|
|
|
|
870,567
|
|
Less: current portion of convertible notes payable
|
|
|
|
|
|
|
|
-
|
|
|
|
855,000
|
|
Long-term convertible notes payable
|
|
|
|
|
|
|
$
|
110,736
|
|
|
$
|
15,567
|
|
The
Company’s convertible notes are convertible, at the option of the holder, into shares of the Company’s common stock.
Borrowings on the Company’s convertible note issued in October 2017 bear interest at the annual rate of 12%.
On
December 6, 2019, the Company and the holder of the Company’s convertible note dated April 13, 2018 (the “April 2018
Note”) entered into an addendum to the underlying promissory note. Pursuant to the addendum, the parties extended the maturity
date of the April 2018 Note to April 13, 2021. In addition, after giving effect to the addendum, the April 2018 Note is non-interest
bearing. All other terms of the April 2018 Note remain unchanged. The Company recorded the transaction as an exchange of debt
instruments with substantially different terms. In connection therewith, the Company recognized a gain on extinguishment of debt
of $13,672. The new debt was recorded net of an initial unamortized debt discount of $13,672, which will be amortized over the
term of the April 2018 Note, as amended.
During
the nine months ended January 31, 2020, the Company settled in full all its obligations under convertible notes with an aggregate
principal amount of $755,000, excluding accrued but unpaid interest of $136,315. During the nine months ended January
31, 2020, the holder of one of the Company’s convertible promissory notes converted $28,000 in accrued but unpaid
interest into 2,800,000 shares of the Company’s class A common stock pursuant to the terms of the promissory note.
During
the three months ended January 31, 2020 and 2019, interest expense in connection with the Company’s convertible notes was
$1,500 and $27,767, respectively, excluding amortization of debt discount of $4,103 and $221,599, respectively. During the nine
months ended January 31, 2020 and 2019, interest expense in connection with the Company’s convertible notes was $45,211
and $140,049, respectively, excluding amortization of debt discount of $9,141 and $1,066,611, respectively.
NOTE
12 - DERIVATIVE LIABILITIES
The
Company analyzed the conversion option for derivative accounting consideration under ASC 815 and determined that the Company’s
convertible notes and stock warrants outstanding at April 30, 2018 should be classified as a liability, under the ASC 815 guidance,
since the conversion options became effective at issuance and there was no explicit limit to the number of shares issuable upon
conversion due to contingencies affecting the conversion rate.
The
Company classifies its derivative liabilities under Level 3 of the three-level hierarchy for measuring fair value (see Note 3
above) and uses a multi-nominal lattice model to calculate the fair value of these liabilities. The multi-nominal lattice model
requires six data inputs including: (1) the exercise or conversion price, (2) the expected term (in years), (3) the expected volatility
for the Company’s common stock, (4) the current stock price, (5) the risk-free interest rate, and (6) the expected dividend
yield. Changes to these inputs could result in a significantly higher or lower fair value measurement.
During
the three months ended October 31, 2018, the Company repaid the convertible notes with a variable conversion rate, a conversion
rate tied to the market price of the Company’s common stock. The remaining convertible notes and warrants outstanding had
a fixed conversion rate and, accordingly, the number of shares issuable upon conversion was determinable with certainty. As a
result, the Company recognized a decrease in its derivative liability resulting in the beneficial conversion feature associated
with the remaining convertible notes and warrants of $1,187,242 (recognized as an increase to additional paid-in capital) and
a gain on fair value of derivatives liabilities of $20,015,840. The Company has no similar derivative liabilities outstanding
during the nine months ended January 31, 2020.
The
following weighted-average assumptions were used when valuing our derivative liabilities:
|
|
|
Nine
Months Ended
January
31, 2019
|
|
Expected
term (in years)
|
|
|
1.0-5.0
|
|
Expected average volatility
|
|
|
107%
- 237%
|
|
Expected dividend yield
|
|
|
-
|
|
Risk-free interest
rate
|
|
|
1.65%
- 2.96%
|
|
The
following table summarizes the changes in the Company’s derivative liabilities during the nine months ended January 31,
2019:
Fair
Value Measurements Using Significant Unobservable Inputs (Level 3)
|
Balance
– April 30, 2018
|
|
$
|
30,488,655
|
|
Addition of new
derivatives recognized as debt discounts
|
|
|
325,000
|
|
Other addition of
new derivatives
|
|
|
679,032
|
|
Reclassification
of derivatives due to tainted instruments
|
|
|
258,132
|
|
Change in fair value
of the derivative
|
|
|
(10,547,737
|
)
|
Reclassification
of derivative to additional paid-in capital
|
|
|
(1,187,242
|
)
|
Change
in derivative liabilities recognized as gain on derivative
|
|
|
(20,015,840
|
)
|
Balance
- January 31, 2019
|
|
$
|
-
|
|
The
following table summarizes the (loss) gain on derivative liability included in our consolidated statement of operations:
|
|
Nine
Months Ended January 31, 2019
|
|
Day-one
loss due to derivative liabilities on convertible notes payable and warrants
|
|
$
|
(679,032
|
)
|
Change in derivative
liabilities
|
|
|
20,015,840
|
|
Gain
from marked-to-market adjustments
|
|
|
10,547,737
|
|
Net
gain on change in fair value of derivative liabilities
|
|
$
|
29,884,545
|
|
NOTE
13 – INCOME TAXES
The
Company is an emerging growth company and, prior to its fiscal quarter ended October 31, 2018, had not generated earnings from
its operations or pre-tax earnings. During its fiscal year ended April 30, 2019 and 2018, the Company’s consolidated operating
loss was $1.1 million and $6.0 million, respectively. During the nine months ended January 31, 2020, the Company’s consolidated
operating earnings were $6.5 million. The Company believes that it is probable it will utilize its available net operating losses
entirely in the foreseeable future. During the nine months ended January 31, 2020, the Company recognized a provision for income
taxes of $1.6 million.
NOTE
14 - RELATED PARTY TRANSACTIONS
Alchemist
Holdings, LLC
In
connection with the Company’s acquisition of Total Travel Media, Inc. in May 2017, the Company issued 7,500,000 shares of
its Series B preferred stock and 7,500,000 shares of its common stock (Class B) to Alchemist Holdings, LLC (“Alchemist”),
an entity which was under the operational control of the then Chairman of our Board of Directors. In connection with the Company’s
acquisition of Four Oceans Holdings, Inc. in September 2017, the Company issued 50,000,000 shares of its Series A preferred stock
to Alchemist. Such shares of Series A preferred stock have since been converted to shares of the Company’s Class A common
stock. The information contained in Note 1 of Notes to the Consolidated Financial Statements located in ITEM 8 – Financial
Statements and Supplementary Data in our Annual Report on Form 10-K for the fiscal year ended April 30, 2019 is incorporated herein
by reference.
Bear
Bull Market Dividends, Inc.
In
connection with the Company’s acquisition of Total Travel Media, Inc., the Company issued 2,500,000 shares of its Series
B preferred stock and 2,500,000 shares of its Class B common stock to Bear Bull Market Dividends, Inc. In connection with the
Company’s acquisition of Four Oceans Holdings, Inc., the Company issued 20,000,000 shares of its Series A preferred stock
to Bear Bull Market Dividends, Inc.
See
Note 16 below for more information about our related parties.
NOTE
15 - STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred
Stock
Series
A Convertible Preferred Stock
During
the nine months ended January 31, 2020, holders of 10,400,000 shares of the Company’s Series
A convertible preferred stock converted their holdings into 10,400,000 shares of
the Company’s common stock.
As
of January 31, 2020, 32,478,750 shares of our Series A convertible
preferred stock remained issued and outstanding.
Series
B Convertible Preferred Stock
As
of January 31, 2020, 10,000,000 shares of our Series B convertible
preferred stock remained issued and outstanding.
Series
C Convertible Preferred Stock
During
the nine months ended January 31, 2020, holders of 50,000 shares of the Company’s
Series C convertible preferred stock converted
their holdings into 50,000 shares of the Company’s common stock. In addition, the Company issued 20,000 shares (in
exchange for cash in the aggregate amount of $5,000) in connection with prior stock subscription agreements.
As
of January 31, 2020, 3,490,000 shares of our Series C convertible
preferred stock remained issued and outstanding.
Common
Stock
As
described above, during the nine months ended January 31, 2020, holders of 10,400,000
shares of the Company’s Series A convertible preferred
stock and holders of 50,000 shares of the Company’s Series C convertible
preferred stock converted their holdings into a respectively equal number of shares of the
Company’s common stock.
During
the nine months ended January 31, 2020, the Company issued 10,000,000 shares of its
class A common stock to a director in connection with his exercise (at an exercise price of $0.0001 per share) of stock warrants
granted under his employment agreement. In addition, the Company issued 215,325 shares of its class A common stock in exchange
for professional or consulting services valued at $57,000, and 30,000 shares of its class A common stock, in exchange for $7,500
in cash, in connection with stock subscription agreements.
During
the nine months ended January 31, 2020, the holder of one of the Company’s
convertible promissory notes converted $28,000 in accrued but unpaid interest into 2,800,000 shares of the Company’s class
A common stock pursuant to the terms of the promissory note. In addition, during the nine months ended January
31, 2020, the Company repurchased from a third-party, in exchange for $500 in cash, and retired 1,500,000 shares of its
class A common stock.
As
of January 31, 2020, 126,072,386 shares of our
class A common stock and 10,000,000 shares of our Class B common stock remained issued and outstanding.
Stock
Warrants
The
following table summarizes the activity relating to the Company’s warrants during the nine months ended January 31, 2020:
|
|
Number of
Warrants
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Term
|
|
Outstanding at April 30, 2019
|
|
|
4,255,133
|
|
|
$
|
0.24
|
|
|
|
2.4
|
|
Granted
|
|
|
27,644,000
|
|
|
$
|
0.0001
|
|
|
|
9.2
|
|
Exercised
|
|
|
10,000,000
|
|
|
$
|
0.0001
|
|
|
|
-
|
|
Expired
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at January 31, 2020
|
|
|
21,899,133
|
|
|
$
|
0.05
|
|
|
|
7.9
|
|
The
following table summarizes certain information relating to outstanding and exercisable warrants:
Warrants Outstanding at January 31, 2020
|
|
Warrants Outstanding
|
|
|
Warrants Exercisable
|
|
|
|
|
Weighted
Average Remaining
|
|
|
Weighted
Average
|
|
|
|
|
|
Weighted
Average
|
|
Number of
Shares
|
|
|
Contractual
life (in years)
|
|
|
Exercise
Price
|
|
|
Number of
Shares
|
|
|
Exercise
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,500,000
|
|
|
|
9.3
|
|
|
$
|
0.0001
|
|
|
|
17,500,000
|
|
|
$
|
0.0001
|
|
|
2,180,000
|
|
|
|
3.3
|
|
|
$
|
0.09
|
|
|
|
2,180,000
|
|
|
$
|
0.09
|
|
|
1,785,800
|
|
|
|
1.1
|
|
|
$
|
0.25
|
|
|
|
1,785,800
|
|
|
$
|
0.25
|
|
|
100,000
|
|
|
|
2.2
|
|
|
$
|
3.00
|
|
|
|
100,000
|
|
|
$
|
3.00
|
|
|
333,333
|
|
|
|
2.7
|
|
|
$
|
0.15
|
|
|
|
333,333
|
|
|
$
|
0.15
|
|
During
the nine months ended January 31, 2020, the Company issued warrants to purchase up to 144,000 shares of the Company’s common
stock to its independent sales force (with an aggregate fair value of $95,267). In addition, the Company issued warrants to purchase,
in the aggregate, up to 27,500,000 shares of the its common stock to two new directors and an employee, with an aggregate fair
value of $5,500,000. The exercise price of these stock warrants is $0.0001 per share.
NOTE
16 - COMMITMENTS AND CONTINGENCIES
Legal
Proceedings
The
Company from time to time is involved in various claims and lawsuits incidental to the conduct of its business in the ordinary
course. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated
financial position, results of operations or cash flows.
Acquisition-Related
Contingencies
In
October 2017, the Company entered into a Share
Exchange Agreement pursuant to which it acquired a 25% equity interest in 561 LLC.
Pursuant to the terms of the Share Exchange Agreement,
in May 2018, the Company increased its cumulative equity interest in 561 LLC to 40% in exchange for 2,500,000 shares of
its Series A Preferred Stock. Under the terms of the Share Exchange Agreement,
the sellers would be entitled to an additional 2,500,000 shares of our Series A Preferred Stock if/when both of the following
conditions have been met: (a) one year has passed from the Closing Date and
(b) the closing bid price of the Company’s common stock equals or exceeds $5.00 per share, as reported by OTC Markets. In
accordance with GAAP, the Company has not recorded a liability in connection with this contingency.
In
October 2017, the Company entered into a Share
Exchange Agreement pursuant to which it acquired a 25% equity interest in America Approved
Commercial LLC (“AAC”). Pursuant to the terms of the Share Exchange
Agreement, in May 2018, the Company increased its cumulative equity interest in AAC to 40%
in exchange for 2,500,000 shares of its Series A Preferred Stock. Under the terms of the
Share Exchange Agreement, the sellers would be entitled to an additional 2,500,000
shares of the Company’s Series A Preferred Stock in/when both of the following conditions have been met: (a) one
year has passed from the Closing Date and (b) the closing bid price of the Company’s common stock equals or
exceeds $5.00 per share, as reported by OTC Markets. In accordance with GAAP, the Company has not recorded a liability in connection
with this contingency.
As
of September 16, 2019, the Company and 212 Technologies, LLC (“212 Technologies”) entered into a Release and Settlement
Agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the parties: (i) rescinded a certain
“Stakeholder & Investment Agreement” dated May 21, 2017 (resulting in the return of 5,628,750 shares of the Company’s
Series A Preferred Stock by 212 Technologies and the return of a 24% ownership stake in 212 Technologies by the Company) and (ii)
terminated a certain “Software License Agreement” dated June 12, 2018 (the “SLA”) by and between 212 Technologies
and Elepreneurs, LLC, a wholly owned subsidiary of the Company (“Elepreneurs”). In connection with the Settlement
Agreement, Elepreneurs agreed to pay 212 Technologies the amount of $425,000 and to dismiss with prejudice a lawsuit it had previously
filed concerning the functionality of the mobile application produced by 212 Technologies under the SLA, and the parties reached
mutually accommodating terms and resolved all issues between their respective companies. As of the date hereof, the shares returned
by 212 Technologies remain outstanding and are held under the terms of a custodian agreement for the benefit of the Company.
Other
Matters
In
January 2019, the Company became aware of an unliquidated amount of potential liability arising from a series of cash advance
loan transactions (the “Loan Transactions”) entered into by eight different lending sources and a Related Party entity
(the “debtor entity”) owned and/or controlled by a former Company officer. Without the knowledge of the Company and
in contravention of the express provisions of both the Company’s Bylaws and the controlling Nevada Revised Statutes, this
former officer also purported to obligate the Company (and two of the Company’s affiliates) to repay the amounts owed by
the debtor entities under the Loan Transactions. At this time, the Company has resolved all of the debt associated with the Loan
Transactions at a substantial discount from the amounts alleged by the holders of such debt. Additionally, the Company has entered
into a comprehensive agreement, secured by substantial assets, with the former officer and the entity owned and/or controlled
by the former officer. Pursuant to such agreement, the former officer and the entity owned and controlled by such former officer
are obligated jointly and severally to repay the Company all sums expended by the Company in the resolution of the Loan Transactions.
The amount expended by the Company, in connection with such resolution, is the sum of $3.4 million. The Company has recorded an
accounts receivable of $3.4 million from the former officer and the entity owned and/or controlled by the former officer. This
amount is reported in accounts receivable, related party in our consolidated balance sheet.
In
June 2019, the Company became aware of a potential liability arising out of certain previous transactions involving the formation
and capitalization of two legal entities affiliated with a Company consultant who was, at the time, considered the Company spokesperson.
Without the knowledge of the Company and in contravention of the express provisions of both the Company’s Bylaws and the
controlling Nevada Revised Statutes, this Company consultant purportedly solicited investment funds from various persons, who
at the time, were independent contractors of the Company. While this matter is still currently under investigation, the Company
has reason to believe that this Company consultant, possibly acting in concert with others, sought to leverage the assets and
resources of the Company in furtherance of these ventures, to their personal pecuniary benefit. Upon learning of these allegations
from various of these investors, the Company launched an immediate internal investigation into these transactions. In addition,
the Company secured the services of a Dallas-based law firm with experience in financial impropriety and forensic investigations
to assist in that process. The Company believes that it is probable that these actions have resulted in a material loss to the
investing parties and is evaluating the potential exposure of these events to the Company. The Company is continuing to finalize
its evaluation and to pursue settlements with the impacted investing parties.
On
July 26, 2019, the Company and certain of its subsidiaries entered into a Settlement Agreement (the “Agreement”) with
Company co-founder and former consultant Robert Oblon. Pursuant to the Agreement and in compromise of a dispute concerning a prior
contractual obligation and various competing claims, the Company agreed to pay Mr. Oblon the aggregate amount of $2.2 million,
payable in 96 equal semi-monthly installments, and stock warrants to purchase up to 7.0 million restricted shares of the Company’s
common stock, subject to limiting conditions. On August 30, 2019, the Company ceased making the installment payments and filed
a lawsuit against Mr. Oblon claiming, among other things, Mr. Oblon’s breach of contract related to this Agreement, as further
discussed below. During the three and nine months ended January 31, 2020, the Company made payments under the Agreement of $0.0
and $235,000, respectively. The Company has recognized an estimated settlement liability of $2.9 million in connection with the
Agreement. Please see Note 17 below.
On
March 28, 2019, Elepreneur, LLC, a wholly owned subsidiary of the Company, and Jordan Brock, a co-founder and former officer of
the Company, entered into a Founder Consulting Agreement pursuant to which Mr. Brock agreed to provide certain business consulting
services to the Company. Under the terms of the Founder Consulting Agreement, the Company agreed to pay Mr. Brock a consultancy
fee at the rate of $15,000 per month. Effective as of July 15, 2019, the Company and Mr. Brock amended the Founder Consulting
Agreement which resulted in the increase of the consultancy fee to $37,000 per month in exchange for Mr. Brock’s willingness
to forgo significant previously negotiated income-earning opportunities with the Company. During the three and nine months ended
January 31, 2020, the Company made payments under the Founder Consulting Agreement of $111,000 and $248,500, respectively.
In
July 2019, Pruvit Ventures, Inc. filed a lawsuit against Elevacity U.S., LLC, a wholly owned subsidiary of the Company, alleging
breach of contract by Elevacity. Elevacity has denied the Plaintiff’s claim. Discovery was propounded on the Plaintiff specifically
related to the alleged act of wrong-doing, responses were received by the Company on December 6, 2019 and the Company is currently
evaluating the responses.
In
August 2019, Entrepreneur Media, Inc. (“EMI”) notified the Company that EMI believes that the Company’s pending
trademark application for “Elepreneurs” would confuse consumers due to the purported similarity to EMI’s existing
trademark for the word “Entrepreneur.” The Company believes that this claim is without merit and intends to vigorously
defend its trademark application. EMI has reached out to the Company and the parties are now engaged in dialogue intended to achieve
a possible amicable resolution.
In
August 2019, the Company filed a lawsuit in the District Court of Collin County, Texas against Kenyatto M. Jones, Bear Bull Market
Dividends, Inc. and Research and Referral, BZ for breach of contract, statutory fraud in a stock transaction, and violations of
the Texas Securities Act. The three defendants purport to be beneficial owners of shares of the Company’s equity securities,
which purported ownership is the subject of the referenced lawsuit. The relief sought in the lawsuit includes both recovery of
damages and rescission of the underlying shares of the Company’s equity securities. Defendants Bear Bull and Jones filed
a Motion to Transfer the complaint in September 2019. A hearing on the Defendants’ Motion to Transfer has been set for April
2, 2020.
On
August 30, 2019, the Company and certain of its affiliated entities filed a lawsuit in the District Court of Collin County, Texas
against Company co-founder and former consultant, Robert Oblon. The lawsuit claims breach of contract related to the Settlement
Agreement dated July 26, 2019 discussed above, tortious interference with business relationships, and misappropriation of trade
secrets, and sought injunctive relief. The Company and such affiliated entities filed an amended petition in September 2019 and
were awarded temporary injunctive relief protecting their intellectual property. The Company and such affiliated entities filed
a second amended petition in December 2019 and were awarded injunctive relief requiring the turnover of certain intellectual and
other property to the Company. Please see Note 17 below.
On
October 1, 2019, the Company filed a complaint in the District Court of Clark County, Nevada entitled Sharing Services Global
Corporation v. Bear Bull Market Dividends, Inc., Alchemist Holdings, LLC, Kenyatto M. Jones, et al. The lawsuit asserts that the
Certificate of Designation for its Series B Preferred Stock filed on or about April 24, 2017 (the “Defective Certificate”)
was in contravention of both the Company’s Articles of Incorporation and Nevada law. Additionally, the lawsuit alleges that
the Defective Certificate was improperly approved through the self-dealing actions of certain former Company executives, working
in collusion with outside shareholders. The lawsuit seeks relief in the form of an injunction enjoining the defendants from attempting
to enforce the provisions of the Defective Certificate and a declaratory judgment that will invalidate the improper portions of
the Defective Certificate. The lawsuit also requests declaratory judgment relief regarding the terms of the Amended and Restated
Certificate of Designation filed by the Company on or about September 26, 2019 (the “Amended Certificate”) which seeks
to correct the improper provisions of the Defective Certificate and to properly realign the rights of the shareholders which were
improperly diminished by the terms of the Defective Certificate. The District Court of Clark County issued a default judgment
against Defendant Bear Bull Market Dividends, Inc. on November 14, 2019 and against Defendant Kenyatto M. Jones on November 15,
2019. The Company is in negotiations with Defendant Alchemist Holdings, LLC and anticipates that a favorable outcome will be reached
in connection with those negotiations.
NOTE
17 - SUBSEQUENT EVENTS
On
February 27, 2020, the Company filed a lawsuit in the District Court of Clark County, Nevada against Kenyatto M. Jones and Bear
Bull Market Dividends, Inc. regarding the matters and courses of action set out in the previously discussed lawsuit filed in August
2019 in the District Court of Collin County, Texas. In the Clark County Nevada lawsuit, the Company is seeking (a) rescission
of the stock transactions described therein, (b) actual, consequential and incidental damages, (c) punitive/exemplary damages,
as well as (d) declaratory and injunctive relief.
Effective
as of February 28, 2020, (a) the Company and the relevant subsidiaries; (b) Robert Oblon (“Oblon”), a Co-Founder of
the Company; (c) Jordan Brock, a Co-Founder of the Company; (d) certain officers and directors of the Company; and (e) certain
other corporate parties entered into a Multi-Party Settlement Agreement (the “Settlement Agreement”) pursuant to which
the foregoing parties agreed to settle all prior disputes among them. This Settlement also resulted in an Order of Dismissal entered
by the various courts in Denton and Collin County, Texas dismissing all litigation matters with prejudice, including an order
dated March 3, 2020 vacating the two previously reported Show Cause Orders. Under the terms of the Settlement Agreement, the Company
agreed to pay Oblon an aggregate amount of $2.3 million and to issue to Oblon 10.0 million restricted shares of its Class A common
stock, $0.0001 par value. In connection with the Settlement Agreement, the parties also exchanged comprehensive, reciprocal, mutual
releases. In addition, the Company and Oblon, terminated the previously announced July 26, 2019 settlement agreement between them.